Question 1

Am I eligible to participate in this study based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study clinical trial (NCT07264426). Contact the study team or your healthcare provider for specific answers.

Question 2

How does efgartigimod compare to other treatments I might consider for CIDP?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study clinical trial (NCT07264426). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of follow-up will I need if I participate in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study clinical trial (NCT07264426). Contact the study team or your healthcare provider for specific answers.

Question 4

What are the potential benefits and risks of starting efgartigimod?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study clinical trial (NCT07264426). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my treatment be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study clinical trial (NCT07264426). Contact the study team or your healthcare provider for specific answers.

Question 6

What should I expect during the treatment process and follow-up visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study clinical trial (NCT07264426). Contact the study team or your healthcare provider for specific answers.

Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Contacts

Sponsors

Related studies

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

Biorepository and Registry for Plasma Exchange Patients

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

Trial snapshot

Condition

Locations shown

For caregivers